These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10757596)
21. Brachytherapy in patients with small prostate glands. Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802 [TBL] [Abstract][Full Text] [Related]
22. The influence of geometrical changes on the dose distribution after I-125 seed implantation of the prostate. Steggerda MJ; Moonen LM; van der Poel HG; Schneider CJ Radiother Oncol; 2007 Apr; 83(1):11-7. PubMed ID: 17349706 [TBL] [Abstract][Full Text] [Related]
23. Comparison of urethral diameters for calculating the urethral dose after permanent prostate brachytherapy. Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H Radiat Med; 2007 Aug; 25(7):329-34. PubMed ID: 17705002 [TBL] [Abstract][Full Text] [Related]
24. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239 [TBL] [Abstract][Full Text] [Related]
26. Comparison of seed loading approaches in prostate brachytherapy. Butler WM; Merrick GS; Lief JH; Dorsey AT Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143 [TBL] [Abstract][Full Text] [Related]
27. Factors predicting for urinary incontinence after prostate brachytherapy. McElveen TL; Waterman FM; Kim H; Dicker AP Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1395-404. PubMed ID: 15275725 [TBL] [Abstract][Full Text] [Related]
28. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy. Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395 [TBL] [Abstract][Full Text] [Related]
29. Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0? Waterman FM; Dicker AP Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):610-21. PubMed ID: 12062604 [TBL] [Abstract][Full Text] [Related]
30. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy. Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722 [TBL] [Abstract][Full Text] [Related]
32. Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance. Holmes DR; Davis BJ; Goulet CC; Wilson TM; Mynderse LA; Furutani KM; Camp JJ; Robb RA Brachytherapy; 2014; 13(5):465-70. PubMed ID: 24962657 [TBL] [Abstract][Full Text] [Related]
33. Use of image coregistration in salvage prostate brachytherapy. Bice WS; Freeman JE; Russell LF; Case GD; Dubois DF; Prete JJ; Prestidge BR Tech Urol; 2000 Jun; 6(2):151-6. PubMed ID: 10798817 [TBL] [Abstract][Full Text] [Related]
34. Can the Day 0 CT-scan predict the post-implant scanning? Results from 136 prostate cancer patients. Cattani F; Vavassori A; Comi S; Gherardi F; Russo S; Orecchia R; Jereczek-Fossa BA Phys Med; 2017 Aug; 40():66-71. PubMed ID: 28743617 [TBL] [Abstract][Full Text] [Related]
35. CT-based postimplant dosimetry of prostate brachytherapy: comparison of 1-mm and 5-mm section CT. Tanaka O; Hayashi S; Kanematsu M; Matsuo M; Nakano M; Maeda S; Deguchi T; Hoshi H Radiat Med; 2007 Jan; 25(1):22-6. PubMed ID: 17225049 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the urethral α/β ratio and tissue repair half-time for iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy. Gocho T; Hori M; Fukushima Y; Someya M; Kitagawa M; Hasegawa T; Tsuchiya T; Hareyama M; Takagi M; Hashimoto K; Masumori N; Sakata KI Brachytherapy; 2020; 19(3):290-297. PubMed ID: 32249179 [TBL] [Abstract][Full Text] [Related]
37. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. Allen ZA; Merrick GS; Butler WM; Wallner KE; Kurko B; Anderson RL; Murray BC; Galbreath RW Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):981-7. PubMed ID: 15989998 [TBL] [Abstract][Full Text] [Related]
38. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. Narayana V; Roberson PL; Pu AT; Sandler H; Winfield RH; McLaughlin PW Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1181-5. PubMed ID: 9169829 [TBL] [Abstract][Full Text] [Related]
39. The effect of the radial function on I-125 seeds used for permanent prostate implantation. Pickett B; Pouliot J Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917 [TBL] [Abstract][Full Text] [Related]
40. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Wallner K; Roy J; Harrison L Int J Radiat Oncol Biol Phys; 1995 May; 32(2):465-71. PubMed ID: 7751187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]